Heterocyclic Anticancer Agents (EPUB)

Original price was: $260.00.Current price is: $10.00.

By Bimal Krishna Banik, Bubun Banerjee Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development,…

SKU: MED-AMB144916
Category: ,
Tags:

Description

By Bimal Krishna Banik, Bubun Banerjee
Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles.

Product Details

  • Publisher ‏ : ‎ Walter de Gruyter; 1st edition (June 21, 2022)
  • Language ‏ : ‎ English
  • Hardcover ‏ : ‎ 532 pages
  • ISBN-10 ‏ : ‎ 3110739267
  • ISBN-13 ‏ : ‎ 978-3110739268

Reviews

There are no reviews yet.

Be the first to review “Heterocyclic Anticancer Agents (EPUB)”

Your email address will not be published. Required fields are marked *